Erna Forgó

21 papers receiving 664 citations

Hit Papers

CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer 2016 · 330 citations
3300+3+6Years since publication100200300

Peers

Erna Forgó
Comparison fields: 5 of 68
  • Pathology and Forensic Medicine 249
  • Cancer Research 184
  • Oncology 332
  • Pulmonary and Respiratory Medicine 256
  • Obstetrics and Gynecology 34
Replace Carla Pinto with:
Carla Pinto Portugal
Alexandre Harlé France
Tom Lesluyes France
Kyle Gowen United States
H. Schimmelpenning Germany
James Sun United States
Billie‐Jo M. Kerns United States
Annette Gylling Finland
Alexandr O. Ivantsov Russia
Hyunjae R. Kim United States
Erna Forgó relative to Carla Pinto Portugal Carla Pinto's profile →
Citations per field
00.5×1.6×
Carla Pinto · 1×
Citations per year

Countries citing papers authored by Erna Forgó

Since Specialization
Citations

This map shows the geographic impact of Erna Forgó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erna Forgó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erna Forgó more than expected).

Fields of papers citing papers by Erna Forgó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erna Forgó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erna Forgó. The network helps show where Erna Forgó may publish in the future.

Co-authors

The 25 scholars most cited alongside Erna Forgó, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erna Forgó Line = papers co-authored together Erna Forgó links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#Work
1
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer
Hit paper breakdown →
2016330
2 2015112
3 201844
4 202038
5 201625
6 201519
7 201018
8 201916
9 202211
10 202011
11 201910
12 20218
13 20226
14 20156
15 20245
16 20214
17 20233
18 20212
19 20242
20 20211

About Erna Forgó

Erna Forgó is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Molecular Biology and Pathology and Forensic Medicine, having authored 21 papers that have together received 672 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (8 papers), Cancer Genomics and Diagnostics (5 papers), Genetic factors in colorectal cancer (3 papers), Ovarian cancer diagnosis and treatment (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Uterine Myomas and Treatments (2 papers), Single-cell and spatial transcriptomics (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (249 citations), Cancer Research (184 citations), Oncology (332 citations), Pulmonary and Respiratory Medicine (256 citations) and Obstetrics and Gynecology (34 citations). Erna Forgó has collaborated with scholars based in United States, South Korea and India. Frequent co-authors include Matt van de Rijn, Xiangqian Guo, Nan Song, Piero Dalerba, Tomer Kalisky, George A. Fisher, Norman Wolmark, Soonmyung Paik, Stephen P. Miranda and J. Brian Hutchison. Their work appears in journals such as Digestive Diseases and Sciences, Clinical Cancer Research, The American Journal of Surgical Pathology, Histopathology and Parasite Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact